COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,845 Articles (22,553 medRxiv, 8,292 bioRxiv)

Most recent first Previous |  Page 1273: Articles 12721-12730  | Next

Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccine in High-Risk Occupational Population: a randomized, parallel, controlled clinical trial
Feng, Y., Chen, J., Yao, T., Chang, Y., Li, X., Xing, R., Li, H., Xie, R., Zhang, X., Wei, Z., Mu, S., Liu, L., Feng, L., Wang, S.
10.1101/2021.08.06.21261696 — Posted: 2021-08-09
COVID-19 Outcomes Among Users of CD20 Inhibitors for Immune-Mediated Diseases: A Comparative Cohort Study
Patel, N. J., D'Silva, K. M., Hsu, T. Y.- T., DiIorio, M. A., Fu, X., Cook, C. E., Prisco, L. C., Martin, L. W., Vanni, K. M. M., Zaccardelli, A., Zhang, Y., Sparks, J. A., Wallace, Z. S.
10.1101/2021.08.05.21261643 — Posted: 2021-08-09
Durability and Cross-Reactivity of Immune Responses Induced by an AS03 Adjuvanted Plant-Based Recombinant Virus-Like Particle Vaccine for COVID-19
Gobeil, P. A. M., Pillet, S., Boulay, I., Charland, N., Lorin, A., Cheng, M., Vinh, D., Boutet, P., Van Der Most, R., Roman, F., de los Angeles Ceregido Perez, M., D'Aoust, M.-A., Landry, N., Ward, B.
10.1101/2021.08.04.21261507 — Posted: 2021-08-09
Assessing unused residual Pfizer-BioNTech Covid-19 vaccine: a community observational study
Hubbard, S. T., Bais, R.
10.1101/2021.08.03.21261569 — Posted: 2021-08-09
The impact of the COVID-19 pandemic on diagnoses of common mental health disorders in adults in Catalonia, Spain
Raventos, B., Pistillo, A., Reyes, C., Fernandez-Bertolin, S., Aragon, M., Berenguera, A., Jacques-Avino, C., Medina-Perucha, L., Burn, E., Duarte-Salles, T.
10.1101/2021.08.06.21261709 — Posted: 2021-08-09
SARS-CoV-2 vaccine effectiveness in immunosuppressed kidney transplant recipients
Chemaitelly, H., AlMukdad, S., Joy, J. P., Ayoub, H. H., YASSINE, H. M., Benslimane, F., Al Khatib, H. A., Tang, P., Hasan, M. R., Coyle, P., Al Kanaani, Z., Al Kuwari, E., Jeremijenko, A., Kaleeckal, A. H., Latif, A. N., Shaik, R. M., Abdul Rahim, H. F., Nasrallah, G., Al Kuwari, M. G., Butt, A. A., Al Romaihi, H. E., Al-Thani, M. H., Alkadi, M. M., Ali, O., Al-Maslamani, M., Bertollini, R., Al Malki, H., Almaslamani, Y., Abu-Raddad, L. J., Al Khal, A.
10.1101/2021.08.07.21261578 — Posted: 2021-08-09
Neuro-COVID long-haulers exhibit broad dysfunction in T cell memory generation and responses to vaccination
Visvabharathy, L., Hanson, B. A., Orban, Z., Lim, P. H., Jain, R., Palacio, N. M., Liotta, E. M., Penaloza-MacMaster, P., Koralnik, I. J.
10.1101/2021.08.08.21261763 — Posted: 2021-08-09 Discussion: Onsite
COVID-19 in Brazilian children and adolescents: findings from 21 hospitals
Liu, P. M. F., de Melo, M. d. C. B., Diniz, L. M. O., Dias, C. d. S., Costa, A. S. d. M., Farace, B. L., da Silva, C. T. C. A., Anschau, F., Aranha, F. G., Nascimento, G. F., Duani, H., Costa, J. H. S. M., Ruschel, K. B., Nogueira, M. C. A., de Oliveira, N. R., Pozza, R., Francisco, S. C., Lage, T. M., Ramires, Y. C., Pereira, D. N., Reis, Z. S. N., Chatkin, J. M., Marcolino, M. S.
10.1101/2021.08.08.21261510 — Posted: 2021-08-09
Ongoing mitigation strategies and further needs of the United States food industry to control COVID-19 in the work environment
Llanos-Soto, S., Bulut, E., Murphy, S. I., Henry, C. J., Zoellner, C., Wiedmann, M., Wetherington, D., Adalja, A., Alcaine, S. D., Ivanek, R.
10.1101/2021.08.06.21261702 — Posted: 2021-08-09
Did Low Risk Perception Mediate the COVID-19 Second Wave in Bangladesh? A Cross-sectional Study on Risk Perception and Preventive Practice
Rahman, F. N., Rahman, A. F., Hossain, S. M., Faiz, M. A., Faisel, A. J., Anwar, A. I., Hossain, M., Hussain, T. M., Mahbub, T., Ali, L.
10.1101/2021.08.08.21257737 — Posted: 2021-08-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).